UnitedHealth: Bigger is Better, Except When It's Not

Stung by declining enrollment, the insurance giant says it is about to jump into the Obamacare exchanges, but competition will be fierce this time around.

Jul 18, 2014 at 2:00PM

Former pitbull of the health insurance world, UnitedHealth (NYSE:UNH) may finally be getting its bite back, based on its Q2 earnings call.

While company execs didn't admit that their sit-on-the-sidelines posture on the Obamacare exchanges proved to be a dud, they at least tossed the strategy in the trash. Company execs said that in 2015, they'll be moving "into as many as 24 states." A not-too-shabby increase, to the tune of sixfold, since the company is only in four exchanges according to the Wall Street Journal.  

On that news, and better-than-expected numbers, the insurance giant's stock ticked up 1.6% for the day. That's in contrast to last quarter's earnings release, which was so depressing UnitedHealth's stock tanked for a month. As a bellwether company, UnitedHealth's last quarter's earnings also temporarily soured the rest of the sector, including rivals Aetna (NYSE:AET) and Wellpoint (NYSE:ANTM).

UnitedHealth's total revenues jumped a better-than-expected 7.1% to $32.6 billion.  Net income came in at $1.41. That's less than last year's $1.44 billion, but per-share earnings were two cents higher than a year earlier, when more shares were outstanding.

The company also improved its overall financial outlook, boosting the low end of its per-share earnings by 10 cents to $5.50-$5.60. The revenue forecast for the year increased to $130 billion. The previous range was $128 billion to $129 billion.

United Health's income tax rate for Q2 climbed from around 35% to more than 41%. An expected increase, as all health insurers will start paying an industrywide tax that is non-deductible this year. UnitedHealth's largest operating expense, medical costs, also climbed 6% to $23 billion.

Second quarter profit slid 2%. The continuing slide in profit is also not a surprise. UnitedHealth said back in December that it expected the new health care law to reduce its after-tax operating earnings by $1.1 billion this year. Consolidated operating margin came in at 7.8%, down 10 basis points from the year-ago quarter.

Gains in Medicare and Medicaid, but market share erosion elsewhere
Total Medicaid growth in the quarter jumped 29% versus last year to $5.8 billion. The gain was unexpected and may bode unexpectedly good quarterly revenue ahead for insurers who are heavy hitters in Medicaid, including Molina Healthcare and Centene.

Medicare and retirement revenue also grew 7% to $732 million.

The number of people served in the senior sectors and internationally grew, helping lead UnitedHealth Group to serve 270,000 more people during the quarter. 

Private health insurance  is still UnitedHealth's biggest business. In the conference call, company execs said that after "closely examining" the first year of the Affordable Care Act and "pricing of rivals," they will be expanding aggressively into the government-run market.

Sounds great, but will it be too late?

Bit competitors (including Aetna and WellPoint) currently all participate in considerably more Obamacare exchanges than UnitedHealth. In addition, many small regional insurers rushed in last year to scoop up share.

There's more exchange competition to deal with than before, and UnitedHealth has seen pressure in its employer market as well. It has had trouble in the New York small business market, according to the Wall Street Journal. In response to the growing competition, UnitedHealth execs have said they believed their competitors were pricing insurance at low rates that wouldn't be sustainable,

In other words, UnitedHealth plans to wait the small guys out--expecting them to drop out or raise prices eventually. But does the company really have that luxury anymore? While UnitedHealth is the market leader in health insurance, there are a lot of other insurers out there competing for market share. And as any sidelined athlete will tell you: being the biggest only conveys an advantage when you're actually competing.

An estimated 13 million people are expected to enroll in Obamacare's next open enrollment period. With its plan for a six-fold increase in exchange participation, UnitedHealth clearly assumes it will be able to snag back its former clients, as well as add a significant number of new ones.

Hopefully, it will happen. But coming from behind is a poor position to be in, even for this powerhouse company. UnitedHealth has a lot of strength, but I believe it will be hard for the company to show as much share-price upside as some of its competitors. As the saying goes, "Scared money doesn't win."

UnitedHealth's sweet spot -- Optum
Meanwhile, thank goodness for Optum.The company's subsidiary turned in its usual superb performance. Optum showed a 23%  increase in year-over-year earnings. The subsidiary is worth its own discussion, suffice it to say here that the division earned nearly a quarter of the corporation's revenues in 2013 and may be the company's best bet for a great future.

Overall, the Street liked what it saw in this quarter's earnings release. In fact, the stock's uptick could have been significantly higher. Shares rose almost 4% in morning trading, before outside news rattled Wall Street.

UnitedHealth's stock was up 13% for 2014 through Thursday's close.

This revolutionary idea could transform US health care
The best investors consistently reap gigantic profits by recognizing true potential earlier and more accurately than anyone else. Let me cut right to the chase. There is a product in development that will revolutionize not just how we treat a common chronic illness, but potentially the entire health industry. Analysts are already licking their chops at the sales potential. In order to outsmart Wall Street and realize multi-bagger returns you will need The Motley Fool’s new free report on the dream-team responsible for this game-changing blockbuster. CLICK HERE NOW.


Cheryl Swanson owns shares of WellPoint. The Motley Fool recommends UnitedHealth Group and WellPoint. The Motley Fool owns shares of WellPoint. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Money to your ears - A great FREE investing resource for you

The best way to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as “binge-worthy finance.”

Feb 1, 2016 at 5:03PM

Whether we're in the midst of earnings season or riding out the market's lulls, you want to know the best strategies for your money.

And you'll want to go beyond the hype of screaming TV personalities, fear-mongering ads, and "analysis" from people who might have your email address ... but no track record of success.

In short, you want a voice of reason you can count on.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich," rated The Motley Fool as the #1 place online to get smarter about investing.

And one of the easiest, most enjoyable, most valuable ways to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as "binge-worthy finance."

Whether you make it part of your daily commute or you save up and listen to a handful of episodes for your 50-mile bike rides or long soaks in a bubble bath (or both!), the podcasts make sense of your money.

And unlike so many who want to make the subjects of personal finance and investing complicated and scary, our podcasts are clear, insightful, and (yes, it's true) fun.

Our free suite of podcasts

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. The show is also heard weekly on dozens of radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable. Rule Breaker Investing and Answers are timeless, so it's worth going back to and listening from the very start; the other three are focused more on today's events, so listen to the most recent first.

All are available for free at www.fool.com/podcasts.

If you're looking for a friendly voice ... with great advice on how to make the most of your money ... from a business with a lengthy track record of success ... in clear, compelling language ... I encourage you to give a listen to our free podcasts.

Head to www.fool.com/podcasts, give them a spin, and you can subscribe there (at iTunes, Stitcher, or our other partners) if you want to receive them regularly.

It's money to your ears.


Compare Brokers